Actively Recruiting
Evaluating Alcohol Use in Alcoholic Liver Disease
Led by Nicole T Shen · Updated on 2019-03-13
160
Participants Needed
1
Research Sites
570 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This prospective, analytic observational study will investigate alcohol recidivism in patients with alcoholic liver disease. All adult subjects presenting with alcoholic liver disease are considered for inclusion. Subjects able to give consent are included.
CONDITIONS
Official Title
Evaluating Alcohol Use in Alcoholic Liver Disease
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Diagnosed with alcoholic liver disease
- Able to provide consent
- Adult between 18 and 80 years old
You will not qualify if you...
- Not diagnosed with alcoholic liver disease
- Unable to provide consent
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
New York Presbyterian Hospital - Weill Cornell Medicine and Columbia University Medical Center
New York, New York, United States, 10021
Actively Recruiting
Research Team
N
Nicole T Shen, MD
CONTACT
R
Robert S Brown, MD, MPH
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here